Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Joseph C. Sardano sold 12,192 shares of the business’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $6.00, for a total value of $73,152.00. Following the sale, the chief executive officer now directly owns 1,605,751 shares of the company’s stock, valued at approximately $9,634,506. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of Sensus Healthcare, Inc. (SRTS) traded up 2.586% during midday trading on Friday, hitting $5.991. The stock had a trading volume of 9,080 shares. Sensus Healthcare, Inc. has a 1-year low of $3.61 and a 1-year high of $6.50. The firm’s market cap is $80.81 million. The firm has a 50-day moving average price of $5.93 and a 200-day moving average price of $5.20.

Sensus Healthcare (NASDAQ:SRTS) last announced its quarterly earnings data on Thursday, August 3rd. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.08. The business had revenue of $4.97 million during the quarter, compared to analyst estimates of $4.50 million. Sensus Healthcare had a negative return on equity of 16.40% and a negative net margin of 13.31%. On average, equities analysts anticipate that Sensus Healthcare, Inc. will post ($0.33) EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/09/15/joseph-c-sardano-sells-12192-shares-of-sensus-healthcare-inc-srts-stock.html.

Separately, Maxim Group began coverage on Sensus Healthcare in a research report on Tuesday, June 6th. They issued a “buy” rating and a $6.50 target price for the company.

An institutional investor recently bought a new position in Sensus Healthcare stock. B. Riley Financial Inc. bought a new position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 104,794 shares of the company’s stock, valued at approximately $421,000. B. Riley Financial Inc. owned about 0.77% of Sensus Healthcare at the end of the most recent reporting period. 10.46% of the stock is owned by institutional investors.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.

Insider Buying and Selling by Quarter for Sensus Healthcare (NASDAQ:SRTS)

Receive News & Ratings for Sensus Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.